ICRH Strategic Plan 2013-2016 – Long descriptions

Figure 2: Cost/Burden of disease

Musculoskeletal diseases was the most costly disease in 2000. The total costs for musculoskeletal diseases included $3.9 billion for direct costs and $18.4 billion for indirect costs. After cardiovascular diseases (CVD), the third highest total cost among all diagnostic categories was for neuropsychiatric conditions ($9.7 billion for direct costs and $10.6 billion for indirect costs) followed by malignant neoplasms ($2.6 billion for direct costs and $14.8 billion for indirect costs). Other diagnostic categories included injuries, which contributed $14.8 billion to the total cost, and diseases and conditions such as digestive diseases, respiratory diseases, sense organ diseases, and respiratory infections, which contributed to less than $9 billion dollars each to the total cost.

These data were based on the total cost of illness of $147.9 billon. Direct costs include hospitals, drugs, and physicians. Expenditures for care in other institutions and additional direct health expenditures were not included.

Indirect costs include mortality, long-term disability, and short-term disability, but not all diagnostic categories include short-term disability costs. The six diagnostic categories that include short-term disability costs are CVD, musculoskeletal diseases, neuropsychiatric conditions, digestive diseases, respiratory diseases, and respiratory infections.

« Back to figure 2

Figure 3: Relative growth in number of funded grants/awards from 2000/01 to 2012/13 according to Institute

Institute Acronym 2000-2001 2010-2011 2012-2013 Fold Change 1 Percentage Fold Change 2 Percentage Fold Change Difference
Aboriginal Peoples' Health IAPH 17 135 139 7.94 794% 8.18 818% 6.94 118
Aging IA 34 481 429 14.15 1415% 12.62 1262% 13.15 447
Cancer Research ICR 273 1043 954 3.82 382% 3.49 349% 2.82 770
Circulatory and Respiratory Health ICRH 407 865 843 2.13 213% 2.07 207% 1.13 458
Gender and Health IGH 27 248 231 9.19 919% 8.56 856% 8.19 221
Genetics IG 292 758 669 2.60 260% 2.29 229% 1.60 466
Health Services and Policy Research IHSPR 91 605 592 6.65 665% 6.51 651% 5.65 514
Human Development, Child and Youth Health IHDCYH 171 604 551 3.53 353% 3.22 322% 2.53 433
Infection and Immunity III 330 1054 982 3.19 319% 2.98 298% 2.19 724
Musculoskeletal Health and Arthritis IMHA 145 531 535 3.66 366% 3.69 369% 2.66 386
Neurosciences, Mental Health and Addiction INMHA 558 1386 1241 2.48 248% 2.22 222% 1.48 828
Nutrition, Metabolism and Diabetes INMD 250 545 554 2.18 218% 2.22 222% 1.18 295
Population and Public Health IPPH 84 563 527 6.70 670% 6.27 627% 5.70 479

« Back to figure 3

Figure 4: Total funds awarded through OOGP grants per ICRH mandated field

2000/
2001		 2001/
2002		 2002/
2003		 2003/
2004		 2004/
2005		 2005/
2006		 2006/
2007		 2007/
2008		 2008/
2009		 2009/
2010		 2010/
2011
Blood $1,959 $2,977 $3,260 $3,363 $3,815 $4,337 $5,172 $8,643 $11,974 $13,048 $13,310
Cardiovascular $28,904 $40,436 $47,932 $52,195 $57,103 $58,282 $56,233 $57,579 $58,367 $52,833 $51,510
Respiratory $10,144 $12,787 $15,053 $15,535 $15,212 $15,634 $17,048 $20,558 $20,714 $20,186 $19,275
Sleep $281 $275 $317 $535 $530 $686 $612 $1,120 $1,171 $1,758 $1,935

« Back to figure 4

Figure 5: Evolution in number of funded trainees, by ICRH mandated field

Blood
2000/
2001		 2001/
2002		 2002/
2003		 2003/
2004		 2004/
2005		 2005/
2006		 2006/
2007		 2007/
2008		 2008/
2009		 2009/
2010		 2010/
2011
Doctoral 7 9 8 8 8 7 4 11 13 18 17
Master's 0 0 0 0 0 1 3 2 2 3 4
Postdoctoral Fellowships 6 7 7 3 6 9 12 17 14 16 14

Cardiovascular
2000/
2001		 2001/
2002		 2002/
2003		 2003/
2004		 2004/
2005		 2005/
2006		 2006/
2007		 2007/
2008		 2008/
2009		 2009/
2010		 2010/
2011
Doctoral 107 108 118 116 105 116 114 108 110 119 109
Master's 0 0 0 0 9 15 25 41 36 46 38
Postdoctoral Fellowships 109 125 132 122 127 111 103 97 79 75 62

Respiratory
2000/
2001		 2001/
2002		 2002/
2003		 2003/
2004		 2004/
2005		 2005/
2006		 2006/
2007		 2007/
2008		 2008/
2009		 2009/
2010		 2010/
2011
Doctoral 15 21 19 25 33 33 39 39 45 46 48
Master's 0 0 0 0 2 7 16 19 17 20 15
Postdoctoral Fellowships 53 58 65 53 40 38 41 37 31 27 27

Sleep
2000/
2001		 2001/
2002		 2002/
2003		 2003/
2004		 2004/
2005		 2005/
2006		 2006/
2007		 2007/
2008		 2008/
2009		 2009/
2010		 2010/
2011
Doctoral 2 2 0 0 1 1 1 3 2 2 5
Master's 0 0 0 0 0 0 1 2 1 0 3
Postdoctoral Fellowships 3 2 1 1 2 2 3 3 3 3 1

« Back to figure 5

Figure 6: Proportion of funding according to four CIHR themes

ICRH 2003 ICRH 2010 CIHR 2003 CIHR 2010
1 - Biomedical 61.4% 56.0% 54.7% 49.1%
2 - Clinical 17.0% 20.0% 10.7% 13.4%
3 - Health Services 5.0% 3.6% 5.0% 6.0%
4 - Population Health 4.1% 7.0% 7.3% 9.5%
Not Specified 12.5% 13.5% 22.3% 22.0%

« Back to figure 6

Figure 7: Relative change in number of cardiovascular clinical trials publication since 1997 on an annual basis, comparing top 10 countries

1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Canada 1.00 1.13 1.31 1.54 1.57 1.55 1.96 1.88 1.78 1.88 2.10 2.41
United States 1.00 0.98 1.18 1.37 1.19 1.37 1.47 1.49 1.53 1.43 1.51 1.55
Germany 1.00 1.22 1.38 1.58 1.38 1.47 1.76 1.65 2.01 1.60 1.71 1.65
United Kingdom 1.00 1.20 1.34 1.39 1.44 1.41 1.42 1.46 1.69 1.27 1.68 1.57
Italy 1.00 1.12 1.29 1.30 1.34 1.54 1.67 1.71 1.97 1.75 2.09 2.08
Netherlands 1.00 1.04 1.31 1.60 1.57 1.49 1.82 1.89 1.90 1.81 2.03 1.99
France 1.00 1.05 1.22 1.33 0.99 1.09 1.08 1.05 1.26 1.25 1.15 1.41
Japan 1.00 0.92 1.15 1.17 1.23 1.39 1.37 1.40 1.52 1.39 1.52 1.50
Sweden 1.00 1.13 1.45 1.42 1.39 1.56 1.39 1.58 1.78 1.27 1.56 1.72
Spain 1.00 1.15 1.56 1.74 1.44 1.64 2.05 2.21 2.54 2.51 2.56 2.23
World 1.00 1.03 1.24 1.30 1.20 1.31 1.42 1.40 1.52 1.44 1.52 1.54

« Back to figure 7

Date modified: